A supportive and performance-enhancing corporate culture is the basis for our success. We place particular importance on respectful interactions and view it as our responsibility, as company management, to actively promote and ensure this culture.

Since 2020, Dr. Friedrich Sernetz has served as CEO of the MiP Pharma Group. He is supported, among others, in key business areas such as Business Development, Regulatory Affairs, and Pharmacovigilance by Dr. Jürgen Mössinger.